14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $137.78 $156.84 Wednesday, 24th Apr 2024 ASND stock ended at $143.18. This is 1.14% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 2.56% from a day low at $141.06 to a day high of $144.68.
90 days $128.67 $161.00
52 weeks $66.03 $161.00

Historical Ascendis Pharma A/S prices

Date Open High Low Close Volume
Oct 28, 2020 $162.82 $164.22 $159.23 $161.06 206 891
Oct 27, 2020 $158.78 $168.56 $156.38 $164.23 265 017
Oct 26, 2020 $159.49 $160.70 $156.48 $158.61 96 870
Oct 23, 2020 $159.67 $160.62 $156.65 $159.75 116 712
Oct 22, 2020 $156.23 $160.31 $156.23 $159.41 73 125
Oct 21, 2020 $156.16 $156.98 $154.16 $156.03 54 414
Oct 20, 2020 $157.22 $157.70 $154.90 $156.00 52 492
Oct 19, 2020 $158.48 $158.98 $155.91 $156.57 83 734
Oct 16, 2020 $158.00 $160.46 $157.44 $158.47 153 423
Oct 15, 2020 $156.25 $159.40 $154.85 $157.50 63 844
Oct 14, 2020 $160.01 $161.33 $156.44 $157.75 113 432
Oct 13, 2020 $159.92 $163.34 $159.13 $160.00 115 295
Oct 12, 2020 $161.39 $161.39 $158.00 $159.89 142 908
Oct 09, 2020 $160.83 $162.08 $159.89 $160.73 144 480
Oct 08, 2020 $164.04 $164.37 $160.62 $160.97 79 611
Oct 07, 2020 $163.57 $164.80 $160.14 $163.75 126 219
Oct 06, 2020 $162.10 $164.98 $161.09 $162.04 122 524
Oct 05, 2020 $159.00 $166.99 $158.81 $161.77 267 139
Oct 02, 2020 $154.25 $159.57 $153.44 $158.63 164 244
Oct 01, 2020 $156.54 $158.07 $153.37 $156.00 148 970
Sep 30, 2020 $152.63 $155.80 $150.03 $154.32 468 363
Sep 29, 2020 $152.13 $154.05 $148.25 $152.26 277 442
Sep 28, 2020 $154.20 $154.72 $149.02 $151.94 207 692
Sep 25, 2020 $147.62 $154.23 $146.84 $154.03 258 726
Sep 24, 2020 $145.44 $149.22 $141.38 $149.22 193 899
Click to get the best stock tips daily for free!

About Ascendis Pharma A/S

Ascendis Pharma A/S Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops Tra... ASND Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT